NCT00964912 - Single Dose Study of BMS-820836 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Depression

Interventions

DRUG

BMS-820836

Oral Solution, Oral, 0.025 mg, single dose, one dose

DRUG

BMS-820836

Oral Solution, Oral, 0.1 mg, single dose, one dose

DRUG

BMS-820836

Oral Solution, Oral, 0.25 mg, single dose, one dose

DRUG

BMS-820836

Oral Solution, Oral, 0.5 mg, single dose, one dose

DRUG

BMS-820836

Oral Solution, Oral, 1 mg, single dose, one dose

DRUG

BMS-820836

Oral Solution, Oral, 2 mg, single dose, one dose

DRUG

BMS-820836

Oral Solution, Oral, 3 mg, single dose, one dose

DRUG

BMS-820836

Oral Solution, Oral, 5 mg, single dose, one dose

DRUG

BMS-820836

Oral Solution, Oral, 8 mg, single dose, one dose

DRUG

Placebo

Oral Solution, Oral, 0 mg, single dose, one dose

DRUG

BMS-820836

Oral Solution, Oral, 3 mg, single dose, one dose

DRUG

BMS-820836

Oral Solution, Oral, 0.5 mg, single dose, one dose

Trial Locations (1)

M5V 2T3

Local Institution, Toronto